Research map: COPD Stability and Asthma Remission: Different Words for the Same Therapeutic Ambition?

Back to the article

Papers in this map

  1. Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD · David A. Lipson · 2018 · 1300 citations · Cited by this paper
  2. Steroid-sparing biologics in severe asthma and chronic obstructive pulmonary disease: a systematic review, cross-disease meta-analysis, and translational estimate of corticosteroid-related harm prevented · Pier‐Valerio Mari · 2026 · Cites this paper
  3. Lipoprotein(a) as a Cardiovascular Risk Factor: Clinical Significance and Therapeutic Perspectives · 2026 · Related
  4. Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD · Klaus Friedrich Rabe · 2020 · 719 citations · Cited by this paper
  5. Advancing Human Placental Modeling Through Stem-Cell-Derived Trophoblast Organoids and Reprogramming Innovations · 2026 · Related
  6. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis · Samantha S.C. Kon · 2014 · 697 citations · Cited by this paper
  7. Effectiveness of Treatment With Tezepelumab in Patients With Severe Asthma, Smoking Asthmatics and Patients With Severe Asthma and COPD: A Real-World Cohort Study · 2026 · Related
  8. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial · Alberto A. Papi · 2018 · 633 citations · Cited by this paper
  9. The Role of Endothelial–Mesenchymal Transition (EndMT) in Aneurysm Formation · 2026 · Related
  10. Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease · Ian Douglas Pavord · 2017 · 626 citations · Cited by this paper
  11. Ectoine Inhibits IL-1β-Induced Inflammation by Suppressing the NF-κB Pathway in Chondrocytes and Alleviates Osteoarthritis in a Rat Model · 2026 · Related
  12. Minimal Clinically Important Differences in Pharmacological Trials · Paul Jones · 2014 · 487 citations · Cited by this paper
  13. Differential Protective Actions of Dulaglutide and Dexamethasone in Methotrexate Induced Pulmonary Fibrosis: Relationship with AMPK and Beclin-1 Levels · 2026 · Related
  14. Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial · Jørgen Vestbo · 2017 · 443 citations · Cited by this paper
  15. Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma: From Targeted Therapy and Combination Strategies to Emerging Therapies · 2026 · Related
  16. An expert consensus framework for asthma remission as a treatment goal · Andrew N Menzies-Gow · 2019 · 439 citations · Cited by this paper
  17. Evaluation of Early and Delayed Meloxicam Treatment Against Regulated Cell Death Pathways and ERK1/2 Phosphorylation in a Rat Model of Renal Ischemia–Reperfusion Injury · 2026 · Related
  18. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial · Dave Singh · 2016 · 432 citations · Cited by this paper
  19. Remission in Global Airway Diseases: EUFOREA Consensus Paper · 2026 · Related
  20. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial · Gary T. Ferguson · 2018 · 409 citations · Cited by this paper
  21. FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease · David A. Lipson · 2017 · 334 citations · Cited by this paper
  22. Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry · P. Jane McDowell · 2023 · 160 citations · Cited by this paper
  23. Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype · Frank C. Sciurba · 2025 · 160 citations · Cited by this paper
  24. Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus · Giorgio Walter Canonica · 2023 · 150 citations · Cited by this paper
  25. Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials · Surya Prakash Bhatt · 2025 · 87 citations · Cited by this paper
  26. Validation of clinical control in COPD as a new tool for optimizing treatment · Juan José Soler‐Cataluña · 2018 · 66 citations · Cited by this paper
  27. The concept of control of COPD in clinical practice · Marc Miravitlles · 2014 · 59 citations · Cited by this paper
  28. Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal? · Dave Singh · 2024 · 58 citations · Cited by this paper
  29. Accelerated FEV 1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients · Hannah R. Whittaker · 2020 · 52 citations · Cited by this paper
  30. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS) · Timothy E. Albertson · 2020 · 51 citations · Cited by this paper
  31. Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma · Umme Kolsum · 2017 · 50 citations · Cited by this paper
  32. The concept of control in COPD: a new proposal for optimising therapy · Juan José Soler‐Cataluña · 2014 · 40 citations · Cited by this paper
  33. Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD · Marc Miravitlles · 2018 · 34 citations · Cited by this paper
  34. Risk factors for FEV1 decline in mild COPD and high-risk populations · Shujing Chen · 2017 · 27 citations · Cited by this paper
  35. SANI clinical remission definition: a useful tool in severe asthma management · Giorgio Walter Canonica · 2024 · 23 citations · Cited by this paper
  36. TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life · Luca Richeldi · 2024 · 21 citations · Cited by this paper
  37. Pro: Clinical remission in asthma – implications for asthma management · Stefania Principe · 2025 · 21 citations · Cited by this paper
  38. Promoting Prevention and Targeting Remission of Asthma · Miloš Jeseňák · 2024 · 18 citations · Cited by this paper
  39. Dupilumab Improves Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation: BOREAS and NOTUS · Surya Prakash Bhatt · 2025 · 15 citations · Cited by this paper

Source: OpenAlex (CC0)